Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucio Cocco

Showing results (131-140 of 238) with videos related to

Pageof 24
Sort By:
International Journal of Molecular Medicine|July 6, 2006
Efficient platelet delta-granule release induced by [Ca2+]i elevation is modulated by GPIIbIIIaGiuliana Gobbi, Ivonne Sponzilli, Prisco Mirandola, et al.
Biomolecules|February 25, 2022
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer CellsJames Andrew McCubrey, Stephen L Abrams, Linda S Steelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemiaMatilde Y Follo, Carlo Finelli, Cristina Clissa, et al.
Journal of Cellular Biochemistry|January 21, 2017
Nuclear Inositide Signaling Via Phospholipase CStefano Ratti, Sara Mongiorgi, Giulia Ramazzotti, et al.
Advances in Biological Regulation|December 12, 2025
Inositide-dependent signal transduction in the nucleus: a virtuous path from the laboratory to the clinicAlessia De Stefano, James A McCubrey, Pann-Ghill Suh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2007
Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblastsCamilla Evangelisti, Pier Luigi Tazzari, Massimo Riccio, et al.
Current Pharmaceutical Design|February 27, 2016
Molecular Mechanisms Underlying Psychological Stress and CancerKyeong Jin Shin, Yu Jin Lee, Yong Ryoul Yang, et al.
Current Pharmaceutical Design|February 23, 2012
Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigeneticsMatilde Y Follo, Sara Mongiorgi, Carlo Finelli, et al.
Handbook of Experimental Pharmacology|January 1, 2020
Inositide-Dependent Nuclear Signalling in Health and DiseaseMatilde Y Follo, Stefano Ratti, Lucia Manzoli, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Nuclear phospholipase C beta1 and cellular differentiationIrene Faenza, Lisa Bregoli, Giulia Ramazzotti, et al.
Pageof 24

Showing results (131-140 of 238) with videos related to

Sort By:
Pageof 24
International Journal of Molecular Medicine|July 6, 2006
Efficient platelet delta-granule release induced by [Ca2+]i elevation is modulated by GPIIbIIIaGiuliana Gobbi, Ivonne Sponzilli, Prisco Mirandola, et al.
Biomolecules|February 25, 2022
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer CellsJames Andrew McCubrey, Stephen L Abrams, Linda S Steelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemiaMatilde Y Follo, Carlo Finelli, Cristina Clissa, et al.
Journal of Cellular Biochemistry|January 21, 2017
Nuclear Inositide Signaling Via Phospholipase CStefano Ratti, Sara Mongiorgi, Giulia Ramazzotti, et al.
Advances in Biological Regulation|December 12, 2025
Inositide-dependent signal transduction in the nucleus: a virtuous path from the laboratory to the clinicAlessia De Stefano, James A McCubrey, Pann-Ghill Suh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 10, 2007
Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblastsCamilla Evangelisti, Pier Luigi Tazzari, Massimo Riccio, et al.
Current Pharmaceutical Design|February 27, 2016
Molecular Mechanisms Underlying Psychological Stress and CancerKyeong Jin Shin, Yu Jin Lee, Yong Ryoul Yang, et al.
Current Pharmaceutical Design|February 23, 2012
Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigeneticsMatilde Y Follo, Sara Mongiorgi, Carlo Finelli, et al.
Handbook of Experimental Pharmacology|January 1, 2020
Inositide-Dependent Nuclear Signalling in Health and DiseaseMatilde Y Follo, Stefano Ratti, Lucia Manzoli, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Nuclear phospholipase C beta1 and cellular differentiationIrene Faenza, Lisa Bregoli, Giulia Ramazzotti, et al.
Pageof 24